Plasma NT1‐tau and Aβ42 correlate with age and cognitive function in two large Down syndrome cohorts is a research paper published in Alzheimer s & Dementia (2023). On theSindex it has a DataRank of 0. It has been cited 9 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01 AG021912
National Institutes of Health
Grant: R01 HD065160
National Institutes of Health
Grant: R56 AG061837
National Institutes of Health
Grant: P01 HD035897
National Institutes of Health
Grant: AG014673
National Institutes of Health
Grant: U01 AG051406
National Institutes of Health
Grant: U01 AG051412
National Institutes of Health
Grant: U19 AG068054
National Institutes of Health
Grant: 1U19AG068054-01
Alzheimer Biomarker Consortium - Down Syndrome (ABC-DS)
National Institutes of Health
Grant: 3UL1TR001857-07S1
University of Pittsburgh Clinical and Translational Science Institute
National Institutes of Health
Grant: 3P30AG072946-02S1
Portable and modular UDS Data Collection software to increase collaboration and engagement of Alzheimer’s Disease Research Center research software engineers
National Institutes of Health
Grant: 5U01AG051406-05
Neurodegeneration in Aging Down Syndrome (NiAD): A Longitudinal Study of Cognition and Biomarkers of Alzheimer's Disease
National Institutes of Health
Grant: 3U54HD087011-05S1
Washington University Intellectual and Developmental Disabilities Research Center-Administrative Down Syndrome Supplement
National Institutes of Health
Grant: 3UL1TR001414-06S1
THE SEARCH FOR COVID-19 PREVENTION AND CURE: ADDRESSING THE CRITICAL ROLE OF INNATE/ADAPTIVE IMMUNITY BY INTEGRATING NOVEL INFORMATICS, TRANSLATIONAL TECHNOLOGIES, AND ONGOING CLINICAL TRIAL RESEARCH
National Institutes of Health
Grant: 5P30AG062715-02
Wisconsin Alzheimer's Disease Research center
National Institutes of Health
Grant: 5R01AG021912-03
Alzheimers Disease in Down Syndrome: Antioxidant Trial
National Institutes of Health
Grant: 3P01HD035897-21S1
Changes in Functioning among Mentally Retarded Adults
National Institutes of Health
Grant: 3P50AG008702-11A1S1
GENES, AGING, LEARNING AND DEMENTIA
National Institutes of Health
Grant: 1R56AG061837-01
Identification of protective factors for cognitive resilience in adults with Down Syndrome: A multi-omic study
National Institutes of Health
Grant: 5P50AG005133-31
AMYLOID DEPOSTION, VASCULAR DISEASE AND CLINICAL PROGRESSION OF AD
National Institutes of Health
Grant: 3U01AG051412-04S2
Biomarkers of Alzheimer's Disease in Adults with Down Syndrome
National Institutes of Health
Grant: 5R01HD065160-02
Predicting Cognitive Decline in Adults with Down Syndrome
National Institutes of Health
Grant: 1UL1TR002345-01
Washington University Institute of Clinical and Translational Sciences
National Institutes of Health
Grant: 5P50AG005681-19
Role of LRP &its ligand tPA in LTP &aging
National Institutes of Health
Grant: 3P30AG066519-01S1
The Alzheimer's Disease Research Center at the University of California, Irvine
National Institutes of Health
Grant: 5U24AG021886-18
National Cell Repository for Alzheimer's Disease (NCRAD)
National Institutes of Health
Grant: 2UL1TR002373-06
University of Wisconsin Institute for Clinical and Translational Research
National Institutes of Health
Grant: 5P30AG062421-03
Massachusetts Alzheimer's Disease Research Center
National Institutes of Health
Grant: 3UL1TR001873-07S1
Clinical and Translational Science Award
National Institutes of Health
Grant: 5U54HD090256-05
Waisman Intellectual and Developmental Disabilities Research Center
Keywords
Sustainable Development Goals